Independent report

SACN-COT statements on potassium-based sodium replacers

Statements from SACN and the Committee on Toxicity (COT) on the health benefits and risks of using potassium-based sodium replacers in the UK.

Documents

SACN-COT statement on potassium-based sodium replacers: assessment of the health benefits and risks of using potassium-based sodium replacers in foods in the UK

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

SACN statement on potassium-based sodium replacers: assessment of the benefits of increased potassium intakes to health

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

In 2013, the Scientific Advisory Committee on Nutrition (SACN) was asked by the Department of Health (DH) to provide advice on the potential risks and benefits of reducing the sodium (salt) content of foods through the use of potassium-based sodium replacers.

A Joint SACN-COT (Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment) working group was convened to conduct a benefit-risk assessment to consider the impact of substituting 15 to 25% of sodium in foods with potassium. The joint assessment integrates advice based on independent position statements published by SACN looking at the potential benefits (see statement above) and by COT looking at the potential risks of increasing potassium intakes.

The joint SACN-COT benefit-risk assessment concludes that overall, at a population level, the potential benefits of using potassium-based sodium replacers to help reduce sodium in foods outweigh the potential risks. The beneficial effects at an individual level are likely to be small in size but will impact a large proportion of the population.

Updates to this page

Published 22 November 2017

Sign up for emails or print this page